PHARMO Institute, part of Lumanity

The PHARMO Institute, part of Lumanity, uses data to derive real-life insights into value of medicines. We provide tailor-made research solutions for: post-authorization safety and efficacy (PASS, PAES) and drug utilization review (DUR); incidence/prevalence, treatment patterns, and patient pathways; comparative effectiveness, including synthetic control arms; healthcare resource use and cost of illness research; validation of surrogacy outcomes; as well as AI patient finding, classification, and disease progression prediction. Disease areas that are addressable in the PHARMO Data Network with ease include slow-progressing illnesses, conditions managed across primary and secondary care settings, and rare diseases where ICD-10 codes are often underutilized....

Pharmacoepidemiology,drug safety,and health outcomes

Pharmo institute, part of lumanity operates in the Pharmaceutical manufacturing industry.

Pharmo institute, part of lumanity's revenue is 11m - 100m

Pharmo institute, part of lumanity has 11 - 50 employees.